Cross-Platform Comparison of Microarray-Based Multiple-Class Prediction
2011

Cross-Platform Consistency for Microarray-Based Multiple-Class Prediction

Sample size: 418 publication Evidence: moderate

Author Information

Author(s): Fan Xiaohui, Shao Li, Fang Hong, Tong Weida, Cheng Yiyu

Primary Institution: Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Hypothesis

Can predictive models trained on one microarray platform accurately predict outcomes on another platform?

Conclusion

The study found that predictive models can be successfully applied across different microarray platforms, which could enhance the use of biomarkers in clinical settings.

Supporting Evidence

  • Models trained on one platform showed comparable performance when predicting outcomes on another platform.
  • Predictive signature genes could be successfully transferred between platforms.
  • Overall prediction accuracy was similar across different microarray platforms.

Takeaway

This study shows that we can use data from different types of microarray machines to make predictions about diseases, which helps doctors find better treatments.

Methodology

The study used toxicogenomics datasets from Affymetrix and Agilent microarray platforms to evaluate model performance and transferability of predictive features across platforms.

Limitations

The study primarily focused on a technical comparison and further research is needed to confirm findings with independent datasets.

Participant Demographics

The study involved 318 treated rats and 100 control rats, all from the same biological samples.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016067

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication